Influence of CYP2D6 genetic polymorphism on ratios of steady-state serum concentrations to dose of the neuroleptic zuclopenthixol
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Influence of CYP2D6 genetic polymorphism on ratios of steady-state serum concentrations to dose of the neuroleptic zuclopenthixol. / Linnet, Kristian; Wiborg, O.
I: Therapeutic Drug Monitoring, Bind 18, 1996, s. 629-634.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Linnet, K & Wiborg, O 1996, 'Influence of CYP2D6 genetic polymorphism on ratios of steady-state serum concentrations to dose of the neuroleptic zuclopenthixol', Therapeutic Drug Monitoring, bind 18, s. 629-634.
APA
Linnet, K., & Wiborg, O. (1996). Influence of CYP2D6 genetic polymorphism on ratios of steady-state serum concentrations to dose of the neuroleptic zuclopenthixol. Therapeutic Drug Monitoring, 18, 629-634.
Vancouver
Linnet K, Wiborg O. Influence of CYP2D6 genetic polymorphism on ratios of steady-state serum concentrations to dose of the neuroleptic zuclopenthixol. Therapeutic Drug Monitoring. 1996;18:629-634.
Author
Bibtex
@article{2a05c2adb93d4fa3b5fec7948bdfdd7d,
title = "Influence of CYP2D6 genetic polymorphism on ratios of steady-state serum concentrations to dose of the neuroleptic zuclopenthixol",
author = "Kristian Linnet and O Wiborg",
year = "1996",
language = "English",
volume = "18",
pages = "629--634",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams & Wilkins",
}
RIS
TY - JOUR
T1 - Influence of CYP2D6 genetic polymorphism on ratios of steady-state serum concentrations to dose of the neuroleptic zuclopenthixol
AU - Linnet, Kristian
AU - Wiborg, O
PY - 1996
Y1 - 1996
M3 - Journal article
VL - 18
SP - 629
EP - 634
JO - Therapeutic Drug Monitoring
JF - Therapeutic Drug Monitoring
SN - 0163-4356
ER -
ID: 43972756